SEC Form 4 · accession 0001171843-15-003457
IMMUNOMEDICS INC · IMMU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M Goldenberg
Officer — CSO & Chairman of the BOD · Director
Period of report
Jun 15, 2015
Accepted (ET)
Jun 16, 2015 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 15, 2015 | M | 150,000 | $1.75 | A | 2,687,696 | D | |
| Common StockF2,F3,F1 | Jun 15, 2015 | S | 82,077 | $4.069 | D | 2,605,619 | D | |
| Common StockF1 | Jun 15, 2015 | M | 120,050 | $2.67 | A | 2,725,669 | D | |
| Common StockF2,F3,F1 | Jun 15, 2015 | S | 90,666 | $4.069 | D | 2,635,003 | D | |
| Common StockF4 | Jun 15, 2015 | M | 70,297 | $1.75 | A | 3,250,165 | I | See Footnote |
| Common StockF5,F6,F4 | Jun 15, 2015 | S | 38,248 | $4.1225 | D | 3,211,917 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F7 | $1.75 | Jun 15, 2015 | M | 150,000 | D | — | Jun 15, 2015 | Common Stock, par value $0.01 per share | 150,000 | 0 | D |
| Stock Option (right to buy)F8 | $2.67 | Jun 15, 2015 | M | 120,050 | D | — | Jul 18, 2015 | Common Stock, par value $0.01 per share | 120,050 | 0 | D |
| Stock Option (right to buy)F9,F7 | $1.75 | Jun 15, 2015 | M | 70,297 | D | — | Jun 15, 2015 | Common Stock, par value $0.01 per share | 70,297 | 0 | I |
Explanation of responses
- F1Includes a total of 190,000 shares held as joint tenants by the reporting person and his spouse, Cynthia L. Goldenberg, also known as Cynthia L. Sullivan, the Issuer's President and Chief Executive Officer.
- F2The price in column 4 is a weighted average price. The prices actually received by in this transaction range from $4.03 to $4.1625.
- F3The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
- F4Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein.
- F5The price in column 4 is a weighted average price. The prices actually received in this transaction range from $4.09 to $4.16.
- F6The reporting person's spouse has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
- F7These stock options were granted pursuant to the Issuer's 2006 Stock Incentive Plan, and vested immediately.
- F8These stock options were granted pursuant to the Issuer's 2006 Stock Incentive Plan, and vested 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter.
- F9The reporting person's spouse was granted these stock options pursuant to the Issuer's 2006 Stock Incentive Plan.